Back to Journals » Drug Design, Development and Therapy » Volume 13

A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study

Total article views   Abstract views HTML views PDF downloads Totals
5,710 Dovepress* 4,505 678+ 1,112 5,183
PubMed Central* 0 527 100 527
Totals 4,505 1,205 1,212 5,710
*Since 24 January 2019
+Since July 2016

View citations on PubMed Central and Google Scholar